Jump to content

Scorpion: Disfigured

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Phediuk (talk | contribs) at 21:53, 12 August 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Developer(s)B-Cool Interactive
Publisher(s)Mamba Games
Platform(s)Microsoft Windows
Release23 October 2009
Genre(s)First-person shooter
Mode(s)Single Player

Scorpion: Disfigured is a first-person shooter with a futuristic setting. It is a classic shooter that incorporates many features from other games of the genre. It features 8 weapons, including numerous traditional and futuristic rifles.

Setting

Scorpion: Disfigured has a unique setting, which take place in a futuristic world that is on the brink of reverting to a time similar to the Middle Ages.

Gameplay

The player has access to two different types of grenades, for use against gun turrets and enemies. There are five varied special abilities, which include night vision, slow-motion and an energy shield. The game features role-playing elements, containing a limited number of upgrades for each special ability. There are twenty large levels, stylised with four different graphic backdrops to provide an estimated twenty-five hours of game play. There are twenty-three types of enemies, each with unique AI behavior. Because of the intelligent and unpredictable AI behavior, Scorpion: Disfigured features very tactically challenging combat. The game has been praised for its impressive in-game graphics and vast number of special effects.

Reception

Scorpion: Disfigured received negative reviews from critics upon release. On Metacritic, the game holds a score of 44/100 based on 5 reviews, indicating "generally unfavorable reviews."[1]

References

  1. ^ a b "Scorpion: Disfigured for PC Reviews". Metacritic. Retrieved 26 December 2017.
  2. ^ Schneider, Christian Fritz (2 April 2009). "Scorpion: Disfigured im Test - Ganz weit weg vom Shooter-Geheimtipp". GameStar. Retrieved 26 December 2017.